E-LIB Suche - Ergebnisse für: Ostermann, H.

1

Hospital admissions in Austria during the COVID-19 Pandemic..:

Ostermann, H ; Eglau, K
European Journal of Public Health. 32 (2022) Supplement_3 - p. , 2022

Link: https://doi.org/10.1093/..

2

Evaluation of a targeted COVID-19 vaccination strategy for ..:

Jahn, B ; Sroczynski, G ; Bicher, M...
European Journal of Public Health. 31 (2021) Supplement_3 - p. , 2021

Link: https://doi.org/10.1093/..

3

A parameter-free population-dynamical approach to health wo..:

Klimek, P ; Gyimesi, M ; Ostermann, H.
European Journal of Public Health. 30 (2020) Supplement_5 - p. , 2020

Link: https://doi.org/10.1093/..

4

Economic evaluation of the Austrian telephone-based triage ..:

Halla, M ; Rainer, L ; Zuba, M..
European Journal of Public Health. 29 (2019) Supplement_4 - p. , 2019

Link: https://doi.org/10.1093/..

5

Epidemiology, patient adherence, and costs of oral mucositi..:

Berger, K. ; Staudenmaier, T. ; Cenzer, I....
Supportive Care in Cancer. 28 (2019) 7 - p. 3113-3123 , 2019

Link: https://doi.org/10.1007/..

6

The Austrian DRG-system: Insights from the first 2 decades:

Ostermann, H ; Bachner, F ; Habimana, K
European Journal of Public Health. 28 (2018) suppl_4 - p. , 2018

Link: https://doi.org/10.1093/..

7

Plerixafor in non-Hodgkin's lymphoma patients: a German ana..:

Hübel, Kai ; Ostermann, H. ; Glaß, Bertram...
Bone Marrow Transplantation. 54 (2018) 1 - p. 123-129 , 2018

Link: https://doi.org/10.1038/..

8

Health system governance via health targets: Insights from ..:

Ostermann, H ; Habimana, K ; Bobek, J.
European Journal of Public Health. 27 (2017) suppl_3 - p. , 2017

Link: https://doi.org/10.1093/..

9

Lenalidomide, adriamycin, dexamethasone for induction follo..:

Knop, S ; Langer, C ; Engelhardt, M...
Leukemia. 31 (2017) 8 - p. 1816-1819 , 2017

Link: https://doi.org/10.1038/..

10

Diagnosis and empirical treatment of fever of unknown origi..:

Heinz, W. J. ; Buchheidt, D. ; Christopeit, M....
Annals of Hematology. 96 (2017) 11 - p. 1775-1792 , 2017

Link: https://doi.org/10.1007/..

11

EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ..:

Borchmann, P. ; Goergen, H. ; Kobe, C....
Hematological Oncology. 35 (2017) S2 - p. 65-65 , 2017

Link: https://doi.org/10.1002/..

12

A cost/benefit analysis of self-care initiatives in the Eur..:

Ostermann, H ; Renner, A ; Schneider, P..
European Journal of Public Health. 25 (2015) suppl_3 - p. , 2015

Link: https://doi.org/10.1093/..

13

Applicability of the EORTC/MSG criteria for IFD in clinical..:

Rieger, H. ; Lustig, D. ; Barlow, S....
Annals of Hematology. 94 (2014) 5 - p. 847-855 , 2014

Link: https://doi.org/10.1007/..

14

Current management of patients hospitalized with complicate..:

Garau, J. ; Ostermann, H. ; Medina, J....
Clinical Microbiology and Infection. 19 (2013) 9 - p. E377-E385 , 2013

Link: https://doi.org/10.1111/..

15

PIN27 Cost Analysis of Voriconazole Versus Liposomal Amphot..:

Ostermann, H. ; Stephens, J. ; Gao, X...
Value in Health. 15 (2012) 7 - p. A389 , 2012

Link: https://doi.org/10.1016/..